Big Molecule Watch
- Celltrion Adalimumab Biosimilar Granted Interchangeability Designation April 18, 2025 Zachariah Holmes
- FDA to Phase Out Animal Testing for Monoclonal Antibodies and Other Drugs April 15, 2025 Darlene Staines
- FDA Approves Biocon Biologics’ Bevacizumab Biosimilar April 11, 2025 Darlene Staines
- Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar April 9, 2025 Darlene Staines
- GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit April 7, 2025 Timothy Beavers
- EMA Seeks Input on a “Tailored Clinical Approach” in Biosimilar Development April 7, 2025 Timothy Beavers
- Accord Receives Positive EMA Opinion for Two Denosumab Biosimilars April 7, 2025 Timothy Beavers
- Global Biosimilar Updates – Spring 2025 April 3, 2025 Seth Manilove|Daniel Farraye
- Commercialization of Ustekinumab and Golimumab Biosimilars April 3, 2025 Alison Siedor
- Henlius Receives Orphan-Drug Designation for HLX22 (anti-HER2 mAb) for Gastric Cancer March 28, 2025 Lihui Bai